Aroa Biosurgery Ltd (ARX)
Australian Securities Exchange · Australia · prices in AUD · close of 22 Oct 2026
Key indicators
| Last close | AUD 0.525 |
|---|---|
| 52-week range | 0.475 – 0.800 |
| Return, 1 month / 3 months | +0.0% / −7.1% |
| Return, 1 year / 3 years | −26.6% / −30.5% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 48.9% |
| Worst drawdown (1 year) | -38.4% |
| Average daily value traded | 0.15M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aroa Biosurgery makes soft tissue regeneration products derived from sheep forestomach tissue. Its dressings and grafts are used by clinicians to help heal wounds and support reconstructive procedures, serving hospitals and healthcare providers in several countries. The company is based in Auckland, New Zealand, and its products are sold to medical professionals and distributors who use them in surgical and wound-care settings.
Aroa Biosurgery Ltd trades under the code ARX on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aroa Biosurgery Ltd (ARX) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.525 on 22 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 661 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 26.6% and over the last three months it fell 7.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -12.1% | ||
| From 52-week high | -34.0% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.1% | ||
| 6-month return | -4.5% | ||
| 12-month return, skipping the last month | -26.6% | ||
| Stability (higher is calmer) | 73 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 48.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.4% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.15M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.8% |
|---|---|
| 1 month | +0.0% |
| 3 months | −7.1% |
| 6 months | −4.5% |
| 1 year | −26.6% |
| 3 years | −30.5% |
| 5 years | −55.1% |
Signals
| 50-day / 200-day average | 0.536 / 0.597 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.023 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.